Rheumatology
News
IVIG may be worthwhile in treatment of refractory active diffuse scleroderma
Key clinical point: IVIG may be worth trying as an adjunctive therapy for active dcSSc in patients failing other therapies. Major finding: The...
News
Immunogenicity to TNF-alpha blockers varies in psoriatic arthritis
Key clinical point: The use of methotrexate should be strongly considered in addition to TNF-alpha blockers in patients with psoriatic arthritis...
News
Rituximab regimen helped to maintain remission of ANCA-associated vasculitis
Key clinical point: A fixed-interval rituximab maintenance regimen was effective in preventing ANCA-associated vasculitis relapse, and the...
News
Psoriasis patients have higher rate of low back pain
News
Preeclampsia in SLE ups CVD risk
Key clinical point: Further research needs to tease out potential links between preeclampsia and heightened risk for CVD. Major finding: Women...
Commentary
What works for tennis elbow
News
Vitamin D landscape marked by lack of consensus
Conference Coverage
Secukinumab tames psoriatic arthritis in FUTURE 2 trial
Key clinical point: Secukinumab could prove to be a major new therapy for psoriatic arthritis. Major finding: After 24 weeks, a response of at...
Conference Coverage
Early discoid lupus onset protective against nephritis
Key clinical point: Discoid lupus erythematosus diagnosed at or before a systemic lupus diagnosis predicts lower risk of lupus nephritis. Major...
Conference Coverage
Consider biopsy for active lupus nephritis in pregnancy
Conference Coverage
Few psoriatic arthritis patients achieve minimal disease activity on methotrexate
Key clinical point: It may be time to rethink methotrexate’s role as first-line therapy for psoriatic arthritis. Major finding: Only 17.4% of...